Evaluation of Fetal Sex in Assisted Reproductive Technology (ART) Achieved Pregnancies
NCT01021085
Fetal Sex Determination
San Diego, California, United States
View Trial DetailsNCT Number: NCT00970047
Whole blood from pregnant women will be collected to develop a noninvasive fetal sex test.
Looking for future studies?
Notify Me18 year–64 year
Female
Observational
IGO, San Diego, California, United States
This is an observational study whereby samples will be tested to determine the presence or absence of fetal Y chromosome genes to test for the fetal sex of the baby. The blood draw will occur between 6 to 16 weeks of gestation. The fetal gender will be requested at or soon after delivery if fetal sex was not previously obtained by CVS or amniocentesis genetic analysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sequenom, Inc.
Industry
Development of a Noninvasive Fetal Sex Determination Test Between 6 and 16 Weeks of Gestation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01021085
Fetal Sex Determination
San Diego, California, United States
View Trial Details